Get in Touch

Direct Equity Investment

Strategic ownership in high-growth companies through active partnership and value creation

Direct Equity Investment

Direct equity investment represents the cornerstone of Epiidosis Investments' capital deployment strategy. We engage in strategic ownership of high-growth companies, targeting businesses with strong value propositions, proven scalability, and clear paths to profitability.

Strategic Ownership

Significant equity stakes in high-potential companies

Active Partnership

Hands-on approach with board participation

Value Creation

Focused on long-term sustainable growth

Long-term Horizon

5-10 year investment period

Our Investment Criteria

Revenue

$5M+ (exceptions for exceptional growth potential)

Business Model

Proven with clear path to profitability

Management

Strong, committed team with relevant experience

Market

$1B+ addressable market

Differentiation

Unique product/service offering

What is Direct Equity?

Direct equity involves investing capital in exchange for an ownership stake in a company, typically a private or pre-IPO firm. This method allows us to participate in decision-making, influence strategic direction, and achieve significant upside potential through various exit strategies.

We believe in active ownership that goes beyond capital provision. Our approach combines financial investment with strategic guidance, operational support, and access to our global network to drive sustainable growth and create lasting value.

Epiidosis Investments L.L.C (DED Commercial License No. 896592, Register No. 1982638, DCCI No. 341676) operates solely as a principal investor, enterprise owner, and project operator under its Dubai Department of Economy and Tourism mainland commercial license. The company is licensed exclusively for investment in, establishment of, and management of enterprises across commercial, industrial, agricultural, tourism, energy, healthcare, education, and oil & gas sectors.

All materials on this website are informational and intended for qualified counterparties coordinating private operating mandates. This website does not constitute an offer, solicitation, or advertisement for any securities, financial products, or regulated services. Epiidosis does not solicit public investment, manage third-party capital, provide investment advisory or brokerage services, or conduct any activity requiring SCA, DFSA, or FSRA authorization.

Any engagement requires bilateral non-disclosure agreements, compliance clearance, and confirmation that accessing this content is lawful in the relevant jurisdiction.